AUGENIMPLANTAT MIT AXITINIB-POLYMORPH IV

Patent europeic · EP4583930 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4583930
Numer da la dumonda
EP24725981
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
09-04-2024
Publitgà
16-07-2025
Concedì
02-09-2026
La protecziun finescha il pli tard
08-04-2044
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
A61L 27/18 (2006.01)
A61K 9/00 (2006.01)
A61L 27/52 (2006.01)
A61L 27/54 (2006.01)
Prioritad
US 202363458558 P 11.04.2023
US 202363546064 P 27.10.2023
US 202363609334 P 12.12.2023
Dumonda PCT
PCT/US2024/023688 09.04.2024
Publicaziun PCT
WO2024/215649 17.10.2024
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 02-09-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 02.09.2026

Partidas

Inventur

BLIZZARD, Charles D.

Bedford, MA 01730, US

KAHN, Erica

Bedford, MA 01730, US

JARRETT, Peter

Bedford, MA 01730, US

GURSES-OZDEN, Rabia

Bedford, MA 01730, US

EL-HAYEK, Rami

Bedford, MA 01730, US

BRAUN, Elizabeth

Bedford, MA 01730, US

IACONA, Joseph

Bedford, MA 01730, US

PATEL, Chintan

Bedford, MA 01730, US

RANSBOTTOM, Mark

Bedford, MA 01730, US

SHERMAN, Olivia

Bedford, MA 01730, US

ISOM, William

Bedford, MA 01730, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.